3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Brain Neoplasms
2
Radiation Injuries
1
Prostatic Neoplasms
1
Popliteal Cyst
1
Pneumonia
1
Optic Neuritis
1
Myelitis, Transverse
1
Myelitis
1
Myasthenia Gravis
1
Glioma
1
Breast Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Methotrexate
4
Abatacept
3
tocilizumab
2
olokizumab
2
Rituximab
2
tofacitinib
1
secukinumab
1
golimumab
1
baricitinib
1
Radioimmunodetection
1
RC-18
1
Etanercept
1
Double-Blind Method
1
Certolizumab Pegol
1
Antirheumatic Agents
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Arthritis, Rheumatoid
×
Adrenal Cortex Hormones
×
Clear all
NCT02046603
2018-12-07
ACT-MOVE
Hoffmann-La Roche
Phase 3
Completed
162 enrolled
30 charts